- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02896686
Efficacy of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure (ILEOMESH)
Multicentric, Prospective, Randomized and Simple Blind Study to Determine the Efficacy of the Placement of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure in Patients With a Prior Rectal Resection for Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary aim of the study is to determine the efficacy of the placement of an onlay mesh for prevention of incisional hernia after loop ileostomy closure in patients with a prior rectal resection for cancer. The efficacy will be evaluated by physical examination 3, 6 and 12 months after surgery and by abdominal CT scan one year after stoma closure.
Secondary aims are to evaluate the tolerability and safety of the prothesis; complications, quality of life and the need for further treatments will be compared between the groups.
This is a multicentric study that will include patients operated on in hospitals in Catalunya for loop ileostomy closure after a prior rectal resection for rectal cancer. Elective surgery for loop ileostomy closure with ASA<4. Exclusion criteria include patients with allergy or intolerance to polypropilene, with a prior mesh on the abdominal wall, ASA ≥IV, patients with a life expectancy of <12 months, chronic renal failure in haemodialysis and patients on steroid therapy.
Patients that agree to participate in the study will be randomized using an electronic formula (Excel) of a uniformly distributed variable assigning case/control randomly until the total number of patients are included.
In the control group, after the digestive tract is reconstructed, the closure of the abdominal wall will be performed with a continuous suture of PDS loop 1/0 following Jenkins 4:1 rule and the skin will be closed using a subcutaneous purse-string closure. Patients in the study group will have the same procedure performed, and after the aponeurosis closure with PDS loop, an onlay light polypropilene mesh will be placed.
Each participant will have an assigned code depending on the participating Centre that will maintain anonymity at all times. All of the information will be registered in a database specifically designed for the study.
Statistical analysis will be performed by a descriptive study of the demographic variables and the incidence of incisional hernia after loop ileostomy closure. A comparative study between the groups will be performed using X2 test for categorical variables and t Student test or U-Mann for continuous variables. A binary logistic regression will also be performed to analyse the influence of each variable and to predict if the interventions produce incisional hernia.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients operated on in hospitals in Catalunya for loop ileostomy closure after a prior rectal resection for rectal cancer.
- elective surgery for loop ileostomy closure
- ASA (American Society of Anesthesiologists)<4
Exclusion Criteria:
- allergy or intolerance to polypropilene
- patients with a prior mesh on the abdominal wall
- ASA ≥IV
- patients with a life expectancy of <12 months
- chronic renal failure in haemodialysis
- patients on steroid therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Abdominal wall closure will be done by continuous polydioxanone (PDS) suture following a SL:WL ratio of 4:1, and the skin will be closed using a subcutaneous purse-string closure
|
The presence of incisional hernia was evaluated by physical examination at scheduled clinical visits (3 and 6 months after surgery) Clinically, an incisional hernia is defined as the presence of a reducible bulge or protrusion at the laparotomy incision scar, palpable during the Valsalva maneuver.
At the end of the follow up (12 Months) a CT scan will be done. Radiologically the incisional hernia is defined as a solution of continuity of the abdominal wall seen on the abdominal CT scan with the patient at rest. The radiologist is blinded to the patient's history and the technique used for fascial closure. |
Experimental: Reinforcement with Mesh
Abdominal wall closure will be done by continous polydioxanone (PDS) suture following a SL:WL ratio of 4:1. The incision is reinforced with onlay placement of a light polypropylene mesh (3 cm wide and the length corresponding to the incision), fixed to the aponeurosis with interrupted polyglactin (Vycril) suture. The skin will be closed using a subcutaneous purse-string closure |
The presence of incisional hernia was evaluated by physical examination at scheduled clinical visits (3 and 6 months after surgery) Clinically, an incisional hernia is defined as the presence of a reducible bulge or protrusion at the laparotomy incision scar, palpable during the Valsalva maneuver.
At the end of the follow up (12 Months) a CT scan will be done. Radiologically the incisional hernia is defined as a solution of continuity of the abdominal wall seen on the abdominal CT scan with the patient at rest. The radiologist is blinded to the patient's history and the technique used for fascial closure.
Reinforcement with Light Polypropylene Mesh
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of incisional hernia
Time Frame: 12 months
|
The primary endpoint is the incidence of incisional hernia, either symptomatic or asymptomatic in the mesh and suture-only groups.
Because appearance of an incisional hernia occurs within the first months after laparotomy, assessment of efficacy was carried out during scheduled clinical visits over a period of 12 months.
The presence of incisional hernia was evaluated by physical examination at scheduled clinical visits and radiologically by an abdominal CT scan performed at the end of follow-up (6 months after operation).
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perioperative complications
Time Frame: 30 days
|
Secondary endpoints are perioperative complications, including wound infection, hematoma, pain and reoperation.
|
30 days
|
Quality of life of the patients
Time Frame: 3, 6 and 12 months after surgery
|
The quality of life was evaluated by the SF-36 Quality of life test, during scheduled clinical visits over a period of 12 months.
|
3, 6 and 12 months after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ILEOMESH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Study Data/Documents
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Incisional Hernia
-
W.L.Gore & AssociatesRecruitingHernia, Ventral | Hernia Incisional | Hernia Incisional VentralUnited States, Spain, Italy, United Kingdom
-
Zagazig UniversityCompletedIncisional Hernia of Midline of Abdomen | Incisional Hernia of Midline of Upper Abdomen | Incisional Hernia of Midline of Lower AbdomenEgypt
-
Mansoura UniversityUnknownHernia, Abdominal | Hernia, Ventral | Hernia IncisionalEgypt
-
C. R. BardCompletedHernia | Hernia, Abdominal | Hernia, IncisionalBelgium, Netherlands, Denmark, France, Italy, United Kingdom, Austria, Germany
-
Hospital Central "Dr. Ignacio Morones Prieto"UnknownHernia, Ventral | Ventral Incisional Hernia
-
Universitaire Ziekenhuizen KU LeuvenBelgian Section for Abdominal Wall Surgery, section of the Royal Belgian...Not yet recruitingVentral Incisional Hernia
-
University of PennsylvaniaCompleted
-
Azienda Sanitaria Locale Napoli 2 NordCompletedHernia, Abdominal | Hernia IncisionalItaly
-
Medtronic - MITGCompletedVentral Incisional HerniaFrance
-
Hospital Regional de Alta Especialidad del BajioCompleted
Clinical Trials on Clinical Follow Up
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Takeshi MorimotoCompletedCoronary Artery DiseaseJapan
-
Rennes University HospitalUnknown
-
M.D. Anderson Cancer CenterRecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Wenzhou Medical University; Jinhua Central Hospital and other collaboratorsRecruitingCoronary Artery DiseaseChina
-
Assistance Publique - Hôpitaux de ParisRecruitingSpinocerebellar Ataxias | Inherited Movement Disorders | Hyperkinetic DisordersFrance
-
Oslo University HospitalCompletedSubarachnoid HemorrhageNorway
-
University of Cape TownMedical Research Council, South AfricaCompleted
-
M.D. Anderson Cancer CenterRecruitingCervical Large Cell Neuroendocrine Carcinoma | Cervical Neuroendocrine Carcinoma | Cervical Small Cell Carcinoma | Cervical Undifferentiated Carcinoma | Stage I Cervical Cancer AJCC v8 | Stage IA Cervical Cancer AJCC v8 | Stage IA1 Cervical Cancer AJCC v8 | Stage IA2 Cervical Cancer AJCC v8 | Stage... and other conditionsUnited States